Company intelligence / Profile preview

J. Roux

Paris, France

Ownership: Private
Development stage: Other

Overview

Laboratoires J. Roux was a French pharmaceutical company primarily focused on the development and commercialization of ophthalmic products. The company was well-known for its specialized eye drops and treatments for ocular conditions, including the Roux-Ocelli line. Historically, it operated as an independent laboratory before being integrated into larger pharmaceutical groups through a series of acquisitions in the French healthcare market. Its legacy products continue to be recognized in the field of ophthalmology, though the entity no longer operates as a standalone business.

Therapeutic areas: Infectious DiseasesImmunologyOphthalmology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on J. Roux.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on J. Roux.

Explore the full profile